Impact of Platelet Glycoprotein IIb/IIIa receptor inhibitors on renal function in patients with acute myocardial infarction treated with primary percutaneous coronary intervention

被引：0
|
作者：
Osherov, A. [1 ]
Aronson, D. [1 ]
Hammerman, H. [1 ]
Kapeliovich, M. [1 ]
Roguin, A. [1 ]
Kerner, A. [1 ]
Grenadier, E. [1 ]
Markiewicz, W. [1 ]
Beyar, R. [1 ]
Nikolsky, E. [1 ]
机构：
[1] Rambam Med Ctr, Haifa, Israel
来源：
EUROPEAN HEART JOURNAL | 2008年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on renal function in patients with ST-segment elevation myocardial infarction treated with primary or rescue percutaneous coronary intervention
    Osherov, Azriel B.
    Roguin, Ariel
    Aronson, Doron
    Grenadier, Ehud
    Kerner, Arthur
    Boulus, Monther
    Kapeliovich, Michael
    Hani, Amad
    Hammerman, Haim
    Beyar, Rafael
    Nikolsky, Eugenia
    [J]. EUROINTERVENTION, 2009, 5 (05) : 604 - 609
  • [2] Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
    Tereshchenko, Andrey S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (06) : 918 - 927
  • [3] The beneficial effect of glycoprotein IIb/IIIa inhibitors in patients with diabetes during primary percutaneous coronary intervention for acute myocardial infarction
    Gruberg, L
    Beyar, R
    Hammerman, H
    Hod, H
    Behar, S
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 230L - 230L
  • [4] Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention
    McCollam, PL
    Foster, DA
    Riesmeyer, JS
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (12) : 1251 - 1256
  • [5] The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction
    Svilaas, T
    van der Horst, ICC
    Zijlstra, F
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (23) : 2479 - 2481
  • [6] Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome
    Crouch, MA
    Nappi, JM
    Cheang, KI
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (06) : 860 - 875
  • [7] Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors
    De Carlo, Marco
    Maselli, Daniele
    Cortese, Bernardo
    Ciabatti, Nicola
    Gistri, Roberto
    Levantino, Maurizio
    Balbarini, Alberto
    De Caterina, Raffaele
    Petronio, Anna Sonia
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 123 (03) : 229 - 233
  • [8] Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes
    Harrington, RA
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06): : 639 - 647
  • [9] Glycoprotein IIb/IIIa Inhibitors in Patients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention
    Anderson, Joe R.
    Riding, Dan
    [J]. CARDIOLOGY IN REVIEW, 2008, 16 (04) : 213 - 218
  • [10] Usefulness of routine unfractionated Heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitors
    Harjai, Kishore J.
    Stone, Gregg W.
    Grines, Cindy L.
    Cox, David A.
    Garcia, Eulogio
    Tcheng, James E.
    Na, Yingbo
    Griffin, John J.
    Guagliumi, Giulio
    Stuckey, Thomas
    Turco, Mark
    Rutherford, Barry D.
    Lansky, Alexandra J.
    Mehran, Roxana
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (02): : 202 - 207
12345